Update from ASH 2018 #2

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Update from ASH 2018 #2

LYMPHOMA CONNECT has summarised the highlights from ASH 2018 for you. An Update on Prognostic Factors in Indolent Lymphomas by Prof. Stefano Luminari, University of Modena and Reggio Emilia, Italy. Abstract 393 – Luminari et al LYMPHOMA CONNECT has summarised the highlights from ASH 2018 for you. An Update on Prognostic Factors in Indolent Lymphomas by Prof. Stefano Luminari, University of Modena and Reggio Emilia, Italy. Abstract 393 – Luminari et al

Prof. Stefano Luminari

Watch the video and download the slides

Prof. Stefano Luminari

Haematologist

University of Modena and Reggio Emilia

Italy

Prof. Stefano Luminari

Haematologist

University of Modena and Reggio Emilia

Italy

Prof Stefano Luminari is Hematologist, Associate professor of Medical Oncology at the University of Modena and Reggio Emilia, in Italy. He is head of the clinical research program for oncohematologic disorders at the Reggio Emilia research Hospital. His activity has been mainly focused on several aspects of clinical research in malignant lymphomas. In particular he is an expert in biomarkers and prognostic studies, in phase II and III clinical trials, and in population based studies. He is an active member of the Fondazione Italiana Linfomi with a leading role in the Indolent lymphoma committee and with a role as PI or co-investigator in several clinical trials mainly focused on follicular lymphomas, Hodgkin lymphomas, aggressive lymphomas (mainly elderly patients) and in the use of PET in lymphomas. He has authored more than 130 peer reviewed manuscripts. Of note, his contribution in the study of FDG-PET in Follicular Lymphoma in the staging (Luminari et al Ann Oncol 2013) and restaging assessment after induction therapy (Luminari et al. Ann Oncol 2014, Trotman J et al. Lancet Hematol 2014) and in the integration of PET with minimal residual disease in the phase of response assessment (Luminari Haematologia 2015). He is active in communicating research data and opinions through social networks (twitter account @stefanoluminari)

time | open 5 min | 2018

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

DOWNLOAD THE SLIDES

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

To hear Prof. Stefano Luminari summarising additional abstracts, please visit the links below:
Abstract 2873 – Freeman et al
Abstract 4095 – Silva et al
Abstract 396 – Pott et al

LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Karyopharm Therapeutics.

Other programmes of interest

Dr Matthew J. Matasar

4 min

Update From ASH 2022

Dec 2022

Asst. Prof. Hans Lee

2 min

Update from ASCO 2022 - Myeloma

May 2022

Dr. Alexander Lesokhin and Dr. Maria Victoria Mateos

Assoc. Prof. María Victoria Mateos

Dr Alexander M Lesokhin

Podcast

20 min

Podcast: Choosing the Best Treatment Regimen in Patients with Hig...

Mar 2022

Dr Matthew J. Matasar

5 min

Lymphoma Update from ASH 2021

Dec 2021

Translating the biology of diffuse large b cell lymphoma into treatment The Oncologist

Dr Matthew J. Matasar

Dr Massimo Magagnoli

Prof. Alexey V Danilov

5 min

DLBCL Review Paper Published in The Oncologist

Jan 2022

Dr Claudio Cerchione

10 min

Update from the 2021 Autumn Congresses in Multiple Myeloma

Nov 2021

Assoc. Prof. Karthik Ramasamy

Assoc. Prof. Joshua Richter

Podcast

25 min

Podcast: Choosing the Best Treatment Regimen in RRMM (Episode 2 o...

Oct 2021

Dr. Joshua Richter and Dr. Karthik Ramasamy

Assoc. Prof. Karthik Ramasamy

Assoc. Prof. Joshua Richter

Podcast

20 min

Podcast: Choosing the Best Treatment Regimen in NDMM (Episode 1 o...

Oct 2021

Assoc. Prof. Tycel Phillips

5 min

Highlights in Lymphoma

Jul 2021

Update from ASCO and EHA 2021 on Multiple Myeloma - LYMPHOMA & MYELOMA CONNECT

Asst. Prof. Hans Lee

5 min

Update from ASCO and EHA 2021 on Multiple Myeloma

Jun 2021

Assoc. Prof. María Victoria Mateos

5 min

Highlights in Multiple Myeloma

Jun 2021

Assoc. Prof. Loretta Nastoupil

5 min

Update from ASH 2018 #1

2018

Other programmes developed by Prof. Stefano Luminari

Prof. Stefano Luminari

Haematologist

University of Modena and Reggio Emilia

Italy

LYMPHOMA CONNECT review paper published in The Oncologist - LYMPHOMA & MYELOMA CONNECT

Prof. Alexey V Danilov

Assoc. Prof. Loretta Nastoupil

Dr Matthew J. Matasar

And others...

0 min

Follicular Lymphoma Review Paper Published in The Oncologist

2019

Prof. Stefano Luminari

E-learning

5 min

Accreditation: EACCME

Chemotherapy-free treatment approaches in lymphoma #3

Feb 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.